|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| - USD | -.--% |
|
-.--% | - |
| 21-01-19 | Integra LifeSciences Holdings Corporation completed the acquisition of ACell, Inc for approximately $410 million. | CI |
| 20-12-22 | ACell, Inc. Announces CE Mark Approval | CI |
| Manager | Title | Age | Since |
|---|---|---|---|
Matthew R. Kunst
DFI | Director of Finance/CFO | - | 2019-12-31 |
Patty Meehan
ADM | Chief Administrative Officer | - | 2001-12-31 |
Jim Kuras
CTO | Chief Tech/Sci/R&D Officer | - | 2019-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 59 | - | |
| Director/Board Member | 71 | 2019-06-30 | |
Kyle C. Kerbawy
CHM | Chairman | 79 | 2015-07-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 340M | |
| +1.59% | +1.87% | -32.35% | -15.45% | 161B | |
| +1.24% | -1.16% | -10.76% | -10.10% | 101B | |
| +1.92% | +1.39% | -2.34% | +49.88% | 56.12B | |
| -0.83% | -1.70% | +54.86% | +48.37% | 53.35B | |
| +1.04% | +3.47% | -13.94% | -42.09% | 42.13B | |
| +5.81% | +15.76% | - | - | 35.29B | |
| +2.24% | -1.28% | -17.61% | -46.42% | 26.57B | |
| +1.67% | +7.22% | +64.10% | -4.57% | 25.79B | |
| +0.82% | +2.48% | -12.51% | -5.64% | 20.69B | |
| Average | +1.54% | +2.80% | +3.68% | -3.25% | 52.22B | |
| Weighted average by Cap. | +1.55% | +2.00% | -6.48% | -2.81% |
| 2018 | 2019 | |
|---|---|---|
| Net sales | 89.22M 78.34M 72.1M 67.19M 127M 8.48B 129M 867M 336M 4.16B 335M 328M 14.49B | 101M 88.5M 81.46M 75.91M 143M 9.58B 146M 980M 380M 4.7B 378M 370M 16.37B |
| Net income | -3.13M -2.75M -2.53M -2.36M -4.45M -298M -4.54M -30.44M -11.79M -146M -11.76M -11.5M -509M | 1.45M 1.27M 1.17M 1.09M 2.06M 138M 2.1M 14.08M 5.46M 67.61M 5.44M 5.32M 235M |
| Net Debt | - | - |
Employees
-
- Stock Market
- Stocks
- ACLL Stock
Select your edition
All financial news and data tailored to specific country editions
